After Decades of Research, Drug Developed at Duke Receives FDA Approval
On October 8, the FDA approved a regenerative medicine based on Louise Markert, M.D., Ph.D.'s, pioneering work as the only therapy
Duke Neuroscientist Co-Leads Massive Effort to Map Brain
Every great exploration refines the map, and in the case of the massive BRAIN initiative funded by the National Institutes of Health, that new draft of the map has just been released.
Racial Disparities in Lung Cancer Outcomes Erased by Equal Access to Top Treatments
Although Black lung cancer patients are more likely to die from their disease than white patients, they have better outcomes than whites when treated with immunotherapies that are now considered th
Three Duke Scientists Awarded NIH Grants for High-Risk, High-Reward Research
The National Institutes of Health (NIH) has awarded grants to three Duke University School of Medicine faculty members through the NIH Common Fund’s High-Risk, High-Reward Research program.
Longtime Donor Establishes a Presidential Distinguished Chair
One day when Carol Deane was an undergraduate biology student at Lake Forest College, a private liberal arts university north of Chicago, she happened to pick up a magazine.
Duke Brain Scientists Named Howard Hughes Medical Institute Investigators
Pandemic Response Shows Path For Improved Health Care in the Future
In many ways, the COVID-19 pandemic forced positive changes in how medicine is practiced in communities and at academic medical centers, with Family Medicine departments working at the front lines
Duke/UNC Awarded Grant to Establish Joint Alzheimer’s Disease Research Center
Duke University and the University of North Carolina at Chapel Hill have been awarded funds from the National Institutes of Health to establish a prestigious Alzheimer’s Disease Research Center (AD
Two new NIH-funded centers to explore impacts of genomic variation in health, disease
Duke University is the recipient of two large grants totaling nearly $12 million from the National Human Genome Research Institute (NHGRI) as part of its new Impact of Genomic Variation on Fun
Duke Opens New Research Campus in Research Triangle Park
When Thomas Denny, MSc, MPhil, professor of medicine and chief operating officer of the Duke Human Vaccine Institute, looks around the br